Market research firm Circana reports that in U.S. multi-outlets and convenience stores for the 52 weeks ending Aug. 11, the ...

Many or all of the products on this page are from partners who compensate us when you click to or take an action on their website, but this does not influence our evaluations or ratings. Our ...

The conversation with Brittany Stopa, MD, Biotech Equity Research Analyst at Guggenheim ... trial evaluating the efficacy and safety of Olvi-Vec in combination platinum-doublet + bevacizumab compared ...

Clinical data update from the NXP800 Phase 1b study expected this month; NXP800 granted Orphan Drug Designation for the treatment of ...

Manager preferences within the artificial intelligence opportunity set are continuing to evolve, with some managers now ...